TSE:ZUH
BMO EqWt US HthCare Hedged CAD (ZUH.TO)
Financials 
Technical Analysis 
May 26, 2026, 12:00 amThis summary was created by AI, based on 1 opinions in the last 12 months.
The BMO EqWt US HthCare Hedged CAD (ZUH-T) fund has garnered positive reviews from experts, highlighting its equal-weight approach that mitigates concentration risks associated with mega-pharmaceutical companies. The fund provides exposure across various healthcare sectors, including pharmaceuticals, biotech, and healthcare services, which are known for their lower volatility. This makes it an attractive option for investors looking to diversify their portfolios amidst narrow leadership trends in the market. The steady demand within the healthcare sector, coupled with strong balance sheets and low economic sensitivity, bodes well for defensive growth. Furthermore, the anticipated innovations driven by artificial intelligence are expected to significantly benefit the healthcare industry, providing an additional growth catalyst.
John HoodThey use a covered call strategy to enhance the yield. Those who want exposure to healthcare space but want higher yield, it is a good option. If yield is not a concern for you, you're better off with ZUH.
Larry Berman CFA, CMT, CTAJohn HoodBilly Kawasaki’s Insights - Picks from 5i Research. Healthcare is likely to be a strong performer in the next five years. Subsectors like medical devices, telemedicine and therapeutics should lead. A good ETF for US exposure. Unlock Premium - Try 5i Free
Stockchase InsightsLarry Berman CFA, CMT, CTAHealthcare ETF? He likes ZUH as it includes pharma, hospitals and other medical services. It is hedged to the Canadian dollar.
John HoodJohn Hood60 names, equally weighted. Prefers names like JNJ, Bristol Myers, UNH, or Merck. His ETF strategy is VHT in US dollars, with more exposure to larger names. Healthcare will be choppy, but it's cheap. Demographics are in its favour.
John Hood
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
BMO EqWt US HthCare Hedged CAD (ZUH.TO) Frequently Asked Questions
What is BMO EqWt US HthCare Hedged CAD stock symbol?
BMO EqWt US HthCare Hedged CAD is a Canadian stock, trading under the symbol ZUH.TO (previously ZUH-T on Stockchase) on the Toronto Stock Exchange (ZUH-CT). It is usually referred to as TSX:ZUH or ZUH.TO
Is BMO EqWt US HthCare Hedged CAD a buy or a sell?
In the last year, there was no coverage of BMO EqWt US HthCare Hedged CAD published on Stockchase.
Is BMO EqWt US HthCare Hedged CAD a good investment or a top pick?
BMO EqWt US HthCare Hedged CAD was recommended as a Top Pick by Mike S. Newton, CIM FCSI on 2019-04-24. Read the latest stock experts ratings for BMO EqWt US HthCare Hedged CAD.
Why is BMO EqWt US HthCare Hedged CAD stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
Is BMO EqWt US HthCare Hedged CAD worth watching?
0 stock analysts on Stockchase covered BMO EqWt US HthCare Hedged CAD in the last year. It is a trending stock that is worth watching.
What is BMO EqWt US HthCare Hedged CAD stock price?
On 2026-05-26, BMO EqWt US HthCare Hedged CAD (ZUH.TO) stock closed at a price of $66.95.
Equal weight avoids concentration in mega-pharma. Pharma, biotech, healthcare services. Lower volatility sector, so it helps diversify against the narrow leadership in the indexes right now. Defensive growth, steady demand in the area, strong balance sheets, low economic sensitivity. Good valuations.
Kicker is lots of healthcare innovation coming due to AI, and this will be a huge benefit.
Disclosure: Owns this for clients via the futures market. Though he may own similar exposure at times, he doesn't own the individual ETF. His team creates the exposure in a different way.